HCV Genotype Distribution and Clinical Characteristics of HCV Mono-Infected and HCV/HIV Co-Infected Patients in Liangshan Prefecture, Sichuan Province, China

被引:1
|
作者
Cao, Bianchuan [1 ]
Liu, Mei [2 ]
Jiang, Tao [2 ]
Yu, Qinghua [2 ]
Yuan, Tianru [2 ]
Ding, Ping [2 ]
Zhou, Xian [2 ]
Huang, Yongmao [1 ]
Zou, Yongsheng [1 ]
Huang, Fuli [1 ,3 ]
机构
[1] Southwest Med Univ, Affiliated Hosp, Luzhou, Peoples R China
[2] First Peoples Hosp Yuexi Cty, Antiviral Therapy Ctr, Liangshan, Peoples R China
[3] Southwest Med Univ, Affiliated Hosp, Dept Infect Dis, 25 Taiping St, Luzhou 646000, Sichuan, Peoples R China
关键词
hepatitis c; HIV; genotype distribution; clinical characteristics; INJECTION-DRUG USERS; VIRUS-INFECTION; DIAGNOSIS;
D O I
10.1177/23259582231217810
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objective: The present study aimed to characterize the genotype distribution and clinical characteristics of HCV monoinfected and HCV/HIV coinfected patients in the Liangshan Prefecture, Sichuan Province, China. Methods: All the patients were divided into HCV monoinfection and HCV/HIV coinfection groups according to whether they were complicated with HIV infection. The data from the two groups were collected. Results: In this study, HCV genotype 3 was the most common genotype in both groups, while HCV genotype 6 was significantly higher in the coinfection group than in the monoinfection group (p = 0.046). The white blood cell count, total bilirubin level, and HCV RNA were significantly higher in the HCV monoinfection group than that in the HCV/HIV coinfection group (p = 0.031; p < 0.001; p = 0.027, respectively). Conclusion: HCV prevalence was high in HIV-positive patients in the Liangshan Prefecture. Thus, incorporating screening and management of HCV monoinfection and HCV/HIV coinfection is needed in local region programs.
引用
收藏
页数:5
相关论文
共 50 条
  • [31] HCV mono-infected and HIV/HCV co-infected individuals treated with direct-acting antivirals: to what extent do they differ?
    Bruno, Giuseppe
    Saracino, Annalisa
    Scudeller, Luigia
    Fabrizio, Claudia
    Dell'Acqua, Raffaele
    Milano, Eugenio
    Milella, Michele
    Ladisa, Nicoletta
    Monno, Laura
    Angarano, Gioacchino
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2017, 62 : 64 - 71
  • [32] The GNB3 C825T polymorphism affects response to HCV therapy with pegylated interferon in HCV/HIV co-infected but not in HCV mono-infected patients
    Nattermann, J.
    Bueren, K.
    Nischalke, H. D.
    Ahlenstiel, G.
    Berg, T.
    Biermer, M.
    Sauerbruch, T.
    Vogel, M.
    Rockstroh, J. K.
    Spengler, U.
    JOURNAL OF HEPATOLOGY, 2007, 46 : S235 - S236
  • [33] Influence of insulin resistance on hepatic fibrosis and steatosis in hepatitis C virus (HCV) mono-infected compared with HIV-HCV co-infected patients
    Halfon, P.
    Penaranda, G.
    Carrat, F.
    Bedossa, P.
    Bourliere, M.
    Ouzan, D.
    Renou, C.
    Tran, A.
    Rosenthal, E.
    Wartelle, C.
    Delasalle, P.
    Cacoub, P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2009, 30 (01) : 61 - 70
  • [34] Prevalence of risk factors for HCV transmission in HIV infected and HIV/HCV co-infected patients
    Bollepalli, S
    Mahthieson, K
    Post, J
    Hillier, A
    Nadir, A
    HEPATOLOGY, 2005, 42 (04) : 423A - 423A
  • [35] Recurrence of hepatitis C virus is more severe in liver transplanted HIV-HCV co-infected patients than in HCV mono-infected patients.
    Vallee, JCD
    Feray, C
    Afonso, AMR
    Castaing, D
    Samuel, D
    LIVER TRANSPLANTATION, 2005, 11 (07) : C2 - C2
  • [36] Effect of mono/dual antiretroviral therapy on HCV and HIV suppression during HCV treatment in HIV/HCV co-infected patients
    Martin-Carbonero, Luz
    Dominguez, Lourdes
    Bailon, Lucia
    Torres, Rafael
    Rubio, Rafael
    Ron, Raquel
    Rico, Mikel
    Jimenez-Nacher, Inmaculada
    Moreno, Francisco
    Gonzalez, Juan
    Pulido, Federico
    Montes, Marisa
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2016, 19
  • [37] Inflammatory cells and apoptosis in HCV and co-infected HCV/HIV patients
    Petrovic, L.
    Rohan, S.
    Hayek, E.
    LIVER INTERNATIONAL, 2006, 26 : 74 - 74
  • [38] Comparison of therapeutic results on HCV and HCV/HIV co-infected patients
    Serra, J. E.
    Guzman, D.
    Velez, J.
    Pinto, P.
    Marques, N. M.
    da Cunha, J. G. Saraiva
    Melico-Silvestre, A.
    JOURNAL OF CLINICAL VIROLOGY, 2006, 36 : S144 - S144
  • [39] Hepatic steatosis progresses faster in HIV mono-infected than HIV/HCV co-infected patients and is associated with liver fibrosis
    Pembroke, Thomas
    Deschenes, Marc
    Lebouche, Bertrand
    Benmassaoud, Amine
    Sewitch, Maida
    Ghali, Peter
    Wong, Philip
    Halme, Alex
    Vuille-Lessard, Elise
    Pexos, Costa
    Klein, Marina B.
    Sebastiani, Giada
    JOURNAL OF HEPATOLOGY, 2017, 67 (04) : 801 - 808
  • [40] Comparison of HCV viral load and its genotype distributions in HCV mono- and HIV/HCV co-infected illicit drug users
    Marzieh Jamalidoust
    Mandana Namayandeh
    Mohsen Moghadami
    Mazyar Ziyaeyan
    Virology Journal, 14